Discontinued Tests
Tests may be discontinued at short notice for various reasons: the majority of discontinuations relate to change with reagent manufacturers or analyser development, supply chain, suspension or regulatory review, etc.
Whilst every effort will be made to look for a replacement referral laboratory, an alternative service may not be available, and it may be difficult to replace these infrequently requested tests for the short or long term. Where possible, samples that have been received by TDL will be referred for a similar service.
The turnaround times, normal values and methodology are, however, likely to be different. If a substitute service cannot be found, you will be notified as it may not always be possible to store samples for the long term. In these instances, it will be necessary to discard or return the sample to the referring service.
| Test | Code | Comment |
|---|---|---|
|
Alpha Fetoprotein on Amniotic fluid |
AFPA |
Effective 03/11/23 |
|
Arabinose |
ARBN |
Effective 23/04/23 |
|
Calreticulin – CALR exon 9 variant screen |
CALR |
16/6/23: Included in ALRP (Leukaemia (Rapid Acute) DNA and RNA NGS Panel) and MPNS (Myeloproliferative Neoplasm NGS Screening Panel) |
|
Cartilage Antibody |
ACA |
Effective 23/04/23 |
|
Collagen Type 1 Cross-Linked N-Telopeptide – NTX |
NTX |
Effective 17/11/23 |
|
Collagen (Type I, II, IV) Antibodies |
COAB |
Test no longer available. Effective 01/03/24 |
|
Coxsackie IgM or Enterovirus IgM |
COXM |
Effective 26/05/23 |
|
Endometrial Immune Profiling Biopsy RNA |
23RF |
Effective 01/02/24. An alternative test Decidualization Score (DS) is available from the same sample type: test code DSRF, TAT 2-3 weeks. |
|
Functional Vitamin B Profile (B1, B2, B6) |
BIOF |
Effective 23/04/23 |
|
Giardia Serology |
GIAR |
Effective 15/07/23 |
|
Glutathione – Red Cell |
GLUR |
Effective 23/04/23 |
|
Glutathione Reductase |
GRED |
Effective 23/04/23 |
|
Gut Permeability Profile (With PEG 400) (Leaky Gut Test) |
GPP |
Effective 23/04/23 |
|
Hair Mineral Analysis |
HMA |
Effective 23/04/23 |
|
Hepcidin |
HPDN |
Effective 17/05/23 |
|
Human Anti-Mouse Ab’s (To Confirm Presence Of Heterophilic Ab’s) |
HAMA |
Effective 23/04/23 |
|
Inner Ear Antigen |
IEA |
Effective 27/10/23 |
|
JAK2 – exon 12 sequencing (rare variants) |
JE12 |
16/6/23: Included in ALRP (Leukaemia (Rapid Acute) DNA and RNA NGS Panel) and MPNS (Myeloproliferative Neoplasm NGS Screening Panel) |
|
JAK2 V617F genotyping assay |
JAK2 |
16/6/23: Included in ALRP (Leukaemia (Rapid Acute) DNA and RNA NGS Panel) and MPNS (Myeloproliferative Neoplasm NGS Screening Panel) |
|
KRAS/NRAS screening assay |
MGP |
12/7/23: Included in ALRP (Leukaemia (Rapid Acute) DNA and RNA NGS Panel) and MPNS (Myeloproliferative Neoplasm NGS Screening Panel) |
|
Kryptopyrroles |
KRYP |
Effective 23/04/23 |
|
LDL7 Subfractions
|
LDL7 |
Temporarily discontinued until further notice. Contact TDL Referrals Department for an update. Effective 16/02/24 |
|
Lead Profile (Hb, ZPP, Lead) |
LEAZ |
Effective 06/24 |
|
Listeria Antibodies |
LIST |
Effective 26/05/23 |
|
Lutein |
LUTE |
Effective 23/04/23 |
|
Lycopene |
LYCO |
Effective 23/04/23 |
|
Mannose Binding Lectin |
MBL |
Effective 11/05/23 |
|
Melanin (Urine) |
MELA |
Effective 23/04/23 |
|
MPL exon 10 analysis |
MPL |
16/6/23: Included in ALRP (Leukaemia (Rapid Acute) DNA and RNA NGS Panel) and MPNS (Myeloproliferative Neoplasm NGS Screening Panel) |
|
Niacin - Blood |
NIAC |
Effective 23/04/23 |
|
NMP22 (Bladder Cancer Marker) |
NMP |
Replaced by UBC - Urinary Bladder cancer antigen 23/04/23 |
|
Noonan Syndrome Prenatal Screen – PTPN11 exons 3 & 11 |
GENE |
Effective 03/11/23 |
|
Novadiage Stool Parasite |
NOVA |
Temporarily suspended until further notice. 17/04/2024. |
|
NPM1 mutascreen assay |
NPM |
16/6/23: Included in ALRP (Leukaemia (Rapid Acute) DNA and RNA NGS Panel) and MPNS (Myeloproliferative Neoplasm NGS Screening Panel) |
|
Pethidine - Urine |
UPET |
Effective 23/04/23 |
|
Poliovirus (Serotypes 1-3) Antibodies By Neutralization |
POLO |
Effective 17/05/23 |
|
Small Intestinal Bacterial Overgrowth Test |
SIBO |
Effective 23/04/23 |
|
T-SPOT®.COVID |
TCEL |
Effective 04/12/23 |
|
Vitamin D2/D3 |
D2D3 |
Effective 23/04/23 |
|
Vitamin K (With PIVKA II) |
VITK |
Temporary suspension until further notice. Please contact Referrals Department for an update. 24/06/24 |
|
Xylose Tolerance Test |
XTT |
Effective from 01/10/2024. |
|
Zinc Protoporphyrin |
ZNPR |
Effective 24/06/23 |